NCT06215625 A Feasible Smart Upper Limb Rehabilitation Model for Patients With Stroke and Spinal Cord Injuries
| NCT ID | NCT06215625 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Cheng-Kung University Hospital |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-01 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2024-01 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to investigate the effectiveness of the developed application and exoskeleton robot devices for home-based training in stroke patients and patients with spinal cord injuries. The application that uses an Internet of Things (IoT) platform to enable remote monitoring of rehabilitation progress by clinical practitioners. Simultaneously, it seeks to assist the execution of patient movements through devices. In patients with stroke, half of the participants will be assigned to experimental group, receiving a smart upper limb motor rehabilitation system for home program. The other half will be assigned to control group, receiving a traditional home program. In patients with spinal cord injuries. Participants will follow the same allocation method for home-based intervention. Researchers will conduct an analysis before and after intervention, examining progress in motor function, activities of daily living, and quality of life.
Eligibility Criteria
Inclusion Criteria: For patients with stroke * 20-79 years old. * The score of Montreal Cognitive Assessment is more than or equal to 26. * The unilateral hemorrhagic or ischemic participants. * The performance of upper limb movement is affected by damage to brain cells. Inclusion Criteria: For patients with spinal cord injury * 20-65 years old. * The score of Mini-Mental Status Examination is more than or equal to 25. * Diagnosed as incomplete spinal cord injury at the C5 or C6 level. Exclusion Criteria: For patients with stroke * Underwent sugery on the shoulder, elbow or wrist. * Severe pain in upper limb. * Another muscular or neurological diseases that effects motor performance. Exclusion Criteria: For patients with spinal cord injury * Underwent sugery on the shoulder, elbow or wrist. * Severe pain in upper limb. * Another muscular or neurological diseases that effects motor performance.
Contact & Investigator
Li-Chieh Kuo, Ph.D
PRINCIPAL INVESTIGATOR
National Cheng Kung University
Frequently Asked Questions
Who can join the NCT06215625 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 79 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06215625 currently recruiting?
Yes, NCT06215625 is actively recruiting participants. Contact the research team at jkkuo@mail.ncku.edu.tw for enrollment information.
Where is the NCT06215625 trial being conducted?
This trial is being conducted at Tainan, Taiwan, Tainan, Taiwan.
Who is sponsoring the NCT06215625 clinical trial?
NCT06215625 is sponsored by National Cheng-Kung University Hospital. The principal investigator is Li-Chieh Kuo, Ph.D at National Cheng Kung University. The trial plans to enroll 90 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.